DIVIDEND ANNOUNCEMENT: Ord/AstraZeneca Plc (NYSE:AZN) on 07/27/2026 declared a dividend of $1.0600 per share

Ord/AstraZeneca Plc (NYSE:AZN) on 07/27/2026 declared a dividend of $ 1.0600 per share payable on September 08, 2026 to shareholders of record as of August 07, 2026. Dividend amount recorded is a decrease of $ 1.11 from last dividend Paid.

Ord/AstraZeneca Plc (NYSE:AZN) has paid dividends since 1993, has a current dividend yield of 1.6778919697% and has increased its dividends for 2 successive years.

Ord/AstraZeneca Plc's market cap is $ 222,182,354,940 and has a PE ratio of 25.49. The stock price closed yesterday at $ 169.26 and has a 52 week low/high of $ 141.77 and $ 212.71.

AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus.

For more information on Ord/AstraZeneca Plc click here.